ECE2015 Eposter Presentations Diabetes (complications & therapy) (143 abstracts)
Bone mineral density in patients with type 1 diabetes mellitus by DEXA and QCT
Eleftheria Mparmpa 1 , Spyros Karamagiolis 2 , Stelios Tigas 3 , Parthena Navrozidou 4 , Marianna Vlychou 4 , Ioannis Fezoulidis 4 , Georgios N Koukoulis 1 & Alexandra Bargiota 1
1Department of Endocrinology and Metabolic Diseases, University of Thessaly, Larissa, Greece; 2General Hospital of Larissa, Larissa, Greece; 3Department of Endocrinology, University of Ioannina, Ioannina, Greece; 4Department of Radiology, University of Thessaly, Larissa, Greece.
Introduction: Type 1 DM (T1DM) has been associated with low bone mineral density (BMD) measured by dual energy X-ray absorptiometry (DEXA) but not with quantitative computed tomography (QCT). QCT provides a three-dimensional image and measures bone’s volume directly as density, independent of the surrounding tissues. The purpose of this study was to evaluate BMD in patients with T1DM using DEXA and QCT.
Methods/design: We studied 81 patients with T1DM (group D) (age: 36+9.7 years, M/F: 32/49) and 70 healthy controls (group C) matched for age, sex, and BMI. In both groups, we measured HbA1c, lumbar spine (LS), and femoral neck (FN) BMD by DEXA and LS BMD by QCT.
Results: Mean BMI (kg/m2) was similar in both groups (D: 23.3+8.1 vs C: 23.7+8.3, P=0.39). In group D, mean duration of diabetes was 16.1+9.9 years and mean HbA1c was 8.1+1.3%. BMD (g/cm2) and z-score measured by DEXA were lower in group D compared to group C at LS (1.02±0.20 vs 1.05±0.14, P=0.03) (−0.31±1.61 vs 0.78±1.76, P=0.01) and at FN (0.69±0.12 vs 0.89±0.11, P=0.043) (−0.1+1.47 vs 1.35±1.04, P=0.037). Also, LS z-scores measured by QCT were lower compared to DEXA (D: −0.16+1.08 vs −0.31±1.61, P=0.022). The lower DEXA z-scores were negative correlated with young onset age (r=−0.74, P=0.021) and longer duration of T1DM (r=−0.78, P=0.032) but not with glycaemic control (r=0.36, P=0.18). In group D, DEXA detected 9/81 patients (11.1%) with osteopenia and 1/81 with osteoporosis (1.2%) at LS and 5/81 (6.2%) with osteopenia and 1/81 with osteoporosis (1.2%) at FN. In contrast, QCT has detected 14/81 patients (17.3%) with osteopenia and 2/81 patients (2.5%) with osteoporosis at LS.
Conclusion: T1DM is associated with lower BMD compared to controls with both methods used. The choice of measuring method may define a different degree of bone loss.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more